NCT04344379View on ClinicalTrials.gov

Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus

PHASE3CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

April 17, 2020

Primary Completion Date

June 18, 2020

Study Completion Date

June 18, 2020

Conditions
SARS-CoV-2 Infection
Interventions
DRUG

hydroxychloroquine

200 mg BID per day

DRUG

azithromycin

250 mg per day

DRUG

hydroxychloroquine placebo

200 mg BID per day

Trial Locations (8)

75012

Hôpital Saint Antoine, Paris

75013

Hôpital Broca, Paris

Hôpital La Pitié-Salpétrière, Paris

75014

Hôpital Cochin, Paris

75015

Hôpital européen Georges Pompidou, Paris

Hôpital Necker, Paris

92100

Hôpital GHU Paris Saclay, Le Kremlin-Bicêtre

93000

Hopial Avicenne, Bobigny

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04344379 - Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus | Biotech Hunter | Biotech Hunter